Postoperative pain has been associated with increased morbidity in surgical patients, but recent studies suggest that pain remains suboptimally controlled.1–3 Scientific evidence on the efficacy of strategies to minimize postoperative pain in pediatric patients is often very limited and various barriers to conduct large randomized trials in children have been identified.4–6 Among those barriers, the unproven safety of a tested intervention can not only decrease patient recruitment but also question the ethics of performing a randomized trial in a vulnerable population.7,8
Transversus abdominis plane (TAP) block has been shown to minimize postsurgical pain in adults undergoing specific procedures.9–11 In contrast, very few and small randomized trials have examined the efficacy of TAP block to minimize postoperative pain in children.12,13 The potential complications of TAP block reported in adults are a major barrier to conduct more randomized trials in children.14,15 The safety of TAP block in children remains to be determined. If proven to have acceptable safety, more randomized studies will be performed to evaluate TAP block efficacy for specific surgical procedures in children.
The major objective of the current investigation was to evaluate the safety of TAP block in pediatric surgical patients. Specifically, we sought to determine the estimated incidence of overall and individual complications related to the performance of TAP block in that patient population. In addition, we evaluated patterns of local anesthetic dosage selection for TAP block placement in children.
The study was performed using data obtained from the Pediatric Regional Anesthesia Network (PRAN) database. Study approval was obtained from the Ann & Robert H. Lurie Children’s Hospital of Chicago IRB. Approval for data collection was obtained from individual sites. All centers granted waiver of informed consent by their IRBs because the data had no patient historical information identifiers, and there were absolutely no changes in patient care. Eligible subjects were pediatric patients (<18 years) undergoing surgery who also received a TAP block for postoperative pain control. The data were collected from April 16, 2007, until December 19, 2012. The data collection form for the current study followed the same variables established by the PRAN group and has been described in detail.16 In brief, the database and data collection instruments were performed with guidance from Axio Research, LLC (Seattle, WA). Data collection started on April 1, 2007, and was performed in 5 centers constituting the steering committee centers (Children’s Hospital Colorado, Aurora, CO; Seattle Children’s Hospital; Ann & Robert H. Lurie Children’s Hospital of Chicago; Lucile Packard Children’s Hospital at Stanford University, Palo Alto, CA; and Children’s Hospital at Dartmouth-Hitchcock Medical Center, Lebanon, NH). Currently, 22 pediatric hospitals nationwide contribute data to the network database (Appendix). Data from each center is entered in a single database supported by Axio Research, LLC. The Web site maximizes data entry efficiency and minimizes errors. The database has been audited multiple times to ensure completeness and accuracy of the data. Incomplete cases are marked and listed in the individual sites’ homepages until full completion of data per each case is achieved. Demographic characteristics included subjects’ age, weight, ASA physical status, and gender. Data on the block performance included patient consciousness status during block performance (awake, sedated, and anesthetized) and the technique used to perform the block (landmark or ultrasound-guided). In addition, the local anesthetic type, dose, volume, and the use of adjuncts were recorded.
A complication from TAP was defined by the presence of at least one of the following intraoperative and/or postoperative factors: inadvertent puncture of the peritoneum, inadvertent puncture of abdominal organs (liver and bowel), vascular puncture (defined by the presence of a blood aspirate), cardiovascular (arrhythmias, hypotension, and cardiac arrest), pulmonary (pneumothorax), neurological (seizure or paresthesia), hematoma, and infection. If a complication was noted, the need for interventions (such as computed tomography, different specialty consultation, and medications) was recorded. In addition, the complication was coded for the time required for resolution and the presence of temporary or permanent sequelae.
Normally distributed interval data are reported as mean (SD). Nonnormally distributed interval and ordinal data are reported as median (range or interquartile range [IQR]), and it was evaluated using Mann-Whitney U test.17,18 Categorical variables are presented as counts and were evaluated using the Fisher exact test. The 95% binomial confidence interval for the incidence of TAP block complications was calculated using the Jeffreys method. The coverage properties of that method are similar to that of others, but it has the advantage of being equal-tailed (e.g., for a 95% confidence interval, the probabilities of the interval lying above or below the true value are both close to 2.5%).19 Because not enough information is available on the dosage of local anesthetics used in TAP block for children and our group has previously demonstrated an association between dose and postoperative pain outcomes,20 an exploratory analysis was also performed to identify patterns of local anesthetic dose and patient demographic characteristic. Simple linear regression was performed using the total local anesthetic dose as a dependent variable and patient characteristics (age and weight as independent variables) for bilateral TAP blocks. When the block was performed using ropivacaine, equipotent doses of ropivacaine were converted to bupivacaine (0.7 mg of bupivacaine = 1 mg of ropivacaine).21,22 A 2-tailed P value of <0.05 was used to reject the null hypothesis.
One thousand nine hundred ninety-four children receiving TAP block were included in the current analysis. Demographic and block characteristics of subjects are presented in Table 1. Before the year 2010, 7 of 151 (5%) blocks were not performed with ultrasound compared to 42 of 1736 (2.5%) in the subsequent years (P = 0.11). Subjects who had their TAP block performed while awake and/or sedated were older than subjects who had TAP block performed under general anesthesia, median (IQR) of 172 (129–192) months and 93 (26–156) months, respectively (P = 0.002). Only 2 complications were reported: vascular aspiration of blood before local anesthetic injection and peritoneal puncture resulting in an overall incidence of complications (95% CI) of 0.1% (0.02%–0.3%) and a specific incidence of complications (vascular aspiration or peritoneal puncture) of 0.05% (0.0054%–0.2%). Both complications did not result in any additional interventions or any subsequent sequelae.
The median (95% range) for the local anesthetic dose per weight for bilateral TAP blocks was 1.0 (0.47–2.29) mg of bupivacaine equivalents per kilogram representing a large variation in clinical practice. There was a direct linear relationship between the total local anesthetic dose and patients’ weights; however, subjects’ weights were not sufficient to explain much of the variability in dose (Fig. 1). Variation in the local anesthetic dose was not explained by age (P = 0.01, R2 = 0.007) or gender (P = 0.34).
The median (IQR) local anesthetic dose/weight was greater when epinephrine was used as a block adjunct compared to that when no epinephrine was used, 1.4 (0.81–1.56) and 1.0 (0.51–1.40) mg of bupivacaine equivalents per kilogram, respectively (P = 0.0001). The weight-based dose in unilateral blocks was significantly lower compared with that of the bilateral doses (0.62 [0.32–0.71] mg of bupivacaine per kilogram and 1.03 [0.72–1.46], P = 0.002), but the analysis was limited by the low number of unilateral cases (n = 7). The absolute dose of local anesthetics was larger in TAP blocks performed with ropivacaine, median (IQR) of 1.27 (0.83–1.97) mg/kg, compared to that in the bupivacaine group, 0.97 (0.64–1.33) mg/kg. In contrast, when adjusting for different local anesthetic potencies, the ropivacaine group, median (IQR) of 0.89 (0.58–1.38) mg of bupivacaine equivalents/kg, received a lower, although not statistically significant, dose than the bupivacaine group, 0.97 (0.64–1.33), P = 0.06.
One hundred thirty-five of 1944 (6.9%; 95% CI, 5.8%–8.1%) subjects received larger doses than commonly used in adults (2 mg of bupivacaine per kilogram) that could be potentially unsafe.23 Subjects who received doses larger than the maximum safe local anesthetic doses were younger than subjects who did not receive potentially unsafe doses, 64 (19–100) months and 108 (45–158) months, respectively (P < 0.001).
The most important finding of the current investigation was the lack of clinically significant complications when TAP blocks were performed in >1900 children. In the current study, we were able to estimate an upper incidence of overall complications of 0.3% that is consistent with other commonly performed regional anesthesia techniques.24–26 More importantly, none of the identified complications had long-term consequences to patients or resulted in additional interventions. Based on our findings, safety concerns should not be a major barrier to the performance of TAP block in children undergoing surgical procedures.
Our results are important due to the lack of enough randomized studies demonstrating the efficacy of regional anesthesia techniques to ameliorate postoperative pain in children.27 The safety of proposed interventions has been repeatedly shown to be a major barrier to the performance of randomized studies in children.7,8 Only few randomized clinical studies have specifically evaluated the efficacy of TAP block to ameliorate pain after pediatric surgery, and safety data originating from those studies were limited by the small number of cases included in those studies.12,13 To the best of our knowledge, the current study is the largest to report on the safety of TAP block in children.
Both complications observed due to the performance of TAP block, that is, a vascular aspiration of blood before local anesthetic injection and a peritoneal puncture, were recognized by the anesthesia provider, which likely resulted in an even lower rate of potential serious complications. The recognition of peritoneal puncture prevents further manipulation of the needle in the peritoneal cavity and potential bowel puncture or lacerations. Similarly, the detection of intravascular placement of the block needle by aspiration avoids intravascular injection of local anesthetics and systemic toxicity.
Another important finding of the current investigation was an almost 5-fold local anesthetic dosage variation used in the performance of TAP block. Our group has previously detected a relationship between local anesthetic dosage and better analgesic outcomes for adults receiving TAP block for laparoscopic surgery.20 It is, therefore, likely that lower doses might not be as effective as commonly used dose regimens (1–2 mg/kg bupivacaine equivalents).20 Clinical practitioners should avoid suboptimal local anesthetic dosage regimens to obtain better postoperative pain when using TAP block in children.
It was also interesting to note that a substantial number of children had received larger doses than what has been reported to be associated with local anesthetic toxic levels in adults.14 It seems that patients who receive bilateral blocks are at greatest risk, but our analysis was limited by the small number of unilateral cases. In addition, subjects’ weights were not sufficient to explain much of the variability in dose and younger patients were more likely to receive potentially unsafe dosages. Because we do not have access to individual site data, it is important that each clinical site reexamine their practice to avoid significant deviations from current clinical practice that can minimize risks to patients.
Our study should only be interpreted in the context of its limitations. The PRAN database does not offer information on surgical procedures, and we could not evaluate the role of different types of surgeries on local anesthetic dosage variations. Because each site has different postoperative analgesic protocols, we could not reliably evaluate the efficacy of TAP block on postoperative pain outcomes. In addition, we did not measure blood levels of local anesthetics in our study population. Because pharmacokinetic drug profiles can be unique in children,28–30 future studies evaluating local anesthetic pharmacokinetic profiles after TAP block are needed.
In summary, we evaluated the safety of TAP block in children. The upper incidence of overall complications was 0.3%. More importantly, complications were very minor and did not require any additional interventions. In contrast, the large variability of local anesthetic dosage currently used in clinical practice can not only minimize potential analgesic benefits of TAP block but also result in potential local anesthetic toxicity. Safety concerns should not be a major barrier to performing randomized trials to test the efficacy of TAP block in children as long as appropriate local anesthetic dose regimens are selected.
Name: Justin B. Long, MD.
Contribution: This author contributed to design and conduct of the study and manuscript preparation.
Attestation: Justin B. Long approved the final manuscript. Justin B. Long attests to the integrity of the original data and the analysis reported in this manuscript.
Name: Patrick K. Birmingham, MD.
Contribution: This author contributed to study design and manuscript preparation.
Attestation: Patrick K. Birmingham approved the final manuscript.
Name: Gildasio S. De Oliveira, Jr, MD, MSCI.
Contribution: This author contributed to design and conduct of the study, data analysis, and manuscript preparation.
Attestation: Gildasio S. De Oliveira, Jr, approved the final manuscript and attests to the integrity of the original data and the analysis reported in this manuscript and is the archival author for data.
Name: Katie M. Schaldenbrand, MPH.
Contribution: This author contributed to study design, data analysis, and manuscript preparation.
Attestation: Katie M. Schaldenbrand approved the final manuscript.
Name: Santhanam Suresh, MD.
Contribution: This author contributed to design and conduct of the study and manuscript preparation.
Attestation: Santhanam Suresh approved the final manuscript and attests to the integrity of the original data and the analysis reported in this manuscript.
This manuscript was handled by: Peter J. Davis, MD.
The authors thank all the participating sites in the PRAN database, the PRAN publication committee, the PRAN steering committee, and Axio Research, LLC for their data collection and cooperative efforts.
1. Salviz EA, Xu D, Frulla A, Kwofie K, Shastri U, Chen J, Shariat AN, Littwin S, Lin E, Choi J, Hobeika P, Hadzic A. Continuous interscalene block in patients having outpatient rotator cuff repair surgery: a prospective randomized trial. Anesth Analg. 2013;117:1485–92
2. Boselli E, Bouvet L, Bégou G, Dabouz R, Davidson J, Deloste JY, Rahali N, Zadam A, Allaouchiche B. Prediction of immediate postoperative pain using the analgesia/nociception index: a prospective observational study. Br J Anaesth. 2014;112:715–21
3. Naja ZM, Ziade FM, El-Rajab MA, Naccash N, Ayoubi JM. Guided paravertebral blocks with versus without clonidine for women undergoing breast surgery: a prospective double-blinded randomized study. Anesth Analg. 2013;117:252–8
4. Muhly W, Gurnaney H, Hosalkar H, Kraemer F, Davidson R, Ganesh A. Continuous perineural infusion after lower extremity osteotomies in children: a feasibility and safety analysis. Br J Anaesth. 2013;110:851–2
5. Dorkham MC, Chalkiadis GA, von Ungern Sternberg BS, Davidson AJ. Effective postoperative pain management in children after ambulatory surgery, with a focus on tonsillectomy: barriers and possible solutions. Paediatr Anaesth. 2014;24:239–48
6. Mamie C, Rebsamen MC, Morris MA, Morabia A. First evidence of a polygenic susceptibility to pain in a pediatric cohort. Anesth Analg. 2013;116:170–7
7. Polanczyk G, Bigarella MP, Hutz MH, Rohde LA. Pharmacogenetic approach for a better drug treatment in children. Curr Pharm Des. 2010;16:2462–73
8. Foster BJ, Warady BA. Clinical research in pediatric nephrology: challenges, and strategies to address them. J Nephrol. 2009;22:685–93
9. Wu Y, Liu F, Tang H, Wang Q, Chen L, Wu H, Zhang X, Miao J, Zhu M, Hu C, Goldsworthy M, You J, Xu X. The analgesic efficacy of subcostal transversus abdominis plane block compared with thoracic epidural analgesia and intravenous opioid analgesia after radical gastrectomy. Anesth Analg. 2013;117:507–13
10. Abdallah FW, Laffey JG, Halpern SH, Brull R. Duration of analgesic effectiveness after the posterior and lateral transversus abdominis plane block techniques for transverse lower abdominal incisions: a meta-analysis. Br J Anaesth. 2013;111:721–35
11. Abdallah FW, Halpern SH, Margarido CB. Transversus abdominis plane block for postoperative analgesia after Caesarean delivery performed under spinal anaesthesia? A systematic review and meta-analysis. Br J Anaesth. 2012;109:679–87
12. Sahin L, Sahin M, Gul R, Saricicek V, Isikay N. Ultrasound-guided transversus abdominis plane block in children: a randomised comparison with wound infiltration. Eur J Anaesthesiol. 2013;30:409–14
13. Fredrickson MJ, Paine C, Hamill J. Improved analgesia with the ilioinguinal block compared to the transversus abdominis plane block after pediatric inguinal surgery: a prospective randomized trial. Paediatr Anaesth. 2010;20:1022–7
14. Griffiths JD, Le NV, Grant S, Bjorksten A, Hebbard P, Royse C. Symptomatic local anaesthetic toxicity and plasma ropivacaine concentrations after transversus abdominis plane block for Caesarean section. Br J Anaesth. 2013;110:996–1000
15. McDermott G, Korba E, Mata U, Jaigirdar M, Narayanan N, Boylan J, Conlon N. Should we stop doing blind transversus abdominis plane blocks? Br J Anaesth. 2012;108:499–502
16. Polaner DM, Taenzer AH, Walker BJ, Bosenberg A, Krane EJ, Suresh S, Wolf C, Martin LD. Pediatric Regional Anesthesia Network (PRAN): a multi-institutional study of the use and incidence of complications of pediatric regional anesthesia. Anesth Analg. 2012;115:1353–64
17. Divine G, Norton HJ, Hunt R, Dienemann J. Statistical grand rounds: a review of analysis and sample size calculation considerations for Wilcoxon tests. Anesth Analg. 2013;117:699–710
18. Dexter F. Wilcoxon-Mann-Whitney test used for data that are not normally distributed. Anesth Analg. 2013;117:537–8
19. Dann RS, Koch GG. Review and evaluation of methods for computing confidence intervals for the ratio of two proportions and considerations for non-inferiority clinical trials. J Biopharm Stat. 2005;15:85–107
20. De Oliveira GS Jr, Castro-Alves LJ, Nader A, Kendall MC, McCarthy RJ. Transversus abdominis plane block to ameliorate postoperative pain outcomes after laparoscopic surgery: a meta-analysis of randomized controlled trials. Anesth Analg. 2014;118:454–63
21. Barreveld A, Witte J, Chahal H, Durieux ME, Strichartz G. Preventive analgesia by local anesthetics: the reduction of postoperative pain by peripheral nerve blocks and intravenous drugs. Anesth Analg. 2013;116:1141–61
22. Lee YY, Ngan Kee WD, Fong SY, Liu JT, Gin T. The median effective dose of bupivacaine, levobupivacaine, and ropivacaine after intrathecal injection in lower limb surgery. Anesth Analg. 2009;109:1331–4
23. Cox B, Durieux ME, Marcus MA. Toxicity of local anaesthetics. Best Pract Res Clin Anaesthesiol. 2003;17:111–36
24. Berde C, Greco C. Pediatric regional anesthesia: drawing inferences on safety from prospective registries and case reports. Anesth Analg. 2012;115:1259–62
25. Shah RD, Suresh S. Applications of regional anaesthesia in paediatrics. Br J Anaesth. 2013;111(Suppl 1):i114–24
26. Ecoffey C. Safety in pediatric regional anesthesia. Paediatr Anaesth. 2012;22:25–30
27. Suresh S, Schaldenbrand K, Wallis B, De Oliveira GS Jr. Regional anaesthesia to improve pain outcomes in pediatric surgicalpatients: a qualitative systematic review of randomized controlled trials. Br J Anaesth.
28. Stricker PA, Zuppa AF, Fiadjoe JE, Maxwell LG, Sussman EM, Pruitt EY, Goebel TK, Gastonguay MR, Taylor JA, Bartlett SP, Schreiner MS. Population pharmacokinetics of epsilon-aminocaproic acid in infants undergoing craniofacial reconstruction surgery. Br J Anaesth. 2013;110:788–99
29. Chalkiadis GA, Abdullah F, Bjorksten AR, Clarke A, Cortinez LI, Udayasiri S, Anderson BJ. Absorption characteristics of epidural levobupivacaine with adrenaline and clonidine in children. Paediatr Anaesth. 2013;23:58–67
30. Drover DR, Hammer GB, Anderson BJ. The pharmacokinetics of ketorolac after single postoperative intranasal administration in adolescent patients. Anesth Analg. 2012;114:1270–6